Kollins John A

CIK 00013910703 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001391070

Recent Transactions

20 trades

Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−505,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−127,659→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−175,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−276,595→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−127,659→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−240,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−127,659→ 0 total
Disposition from Tender
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2023-06-06$0.91/sh−305,911→ 0 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-03+505,000→ 505,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-12-03+240,000→ 240,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-03-04+175,000→ 175,000 total
Disposition to Issuer
Paratek Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-10-30−7,083→ 0 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock
2014-10-30$21.59/sh+4,161→ 4,161 total
Disposition to Issuer
Paratek Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-10-30−9,583→ 0 total
Disposition to Issuer
Paratek Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-10-30−4,166→ 0 total
Disposition to Issuer
Paratek Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-10-30−7,500→ 0 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2013-07-15+115,000→ 115,000 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2013-01-07+90,000→ 90,000 total
Award
Paratek Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2012-06-20+85,000→ 85,000 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Stock Option (Right to Buy)
2009-01-20+250,000→ 250,000 total

Companies

Recent Filings

Address

C/O OXIGENE, INC., 230 THIRD AVENUE

WALTHAM, MA, 02451

View on SEC.gov